Parkinson’s disease Therapeutics Market to Witness Huge Growth by 2024
Date: 2018-09-13   Author: Rahul Sankrityayan  Category: #industry

Parkinson’s disease Therapeutics Market to Witness Huge Growth by 2024

Global Parkinson’s disease Market size is projected to experience significant growth from 2017 to 2024.

Parkinson’s disease therapeutic market is expected to witness significant growth due to increasing cases of Parkinson’s disease with the increase in aging population. As per the Parkinson’s Foundation, one million Americans are suffering from Parkinson Disease. Every year, around 60,000 Americans are diagnosed with Parkinson’s disease and this number is expected to be triple over next 50 years with the increase in aging population. Therefore, it will drastically result in increasing the market size during the forecasted period.

Get Table of Content of this Report @  https://www.gminsights.com/request-toc/upcoming/2724

Advancement in treatment such as development of the combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation is driving the market growth. Other factors such as robust pipeline, growing government and pharmaceutical companies’ initiatives for the development of the novel therapies, promising pipeline drugs for Parkinson’s disease are stimulating the growth of the market.

Patent expiry of blockbuster drugs such as Azilect (rasagiline mesylate), Stalevo (levodopa, carbidopa, entacapone) and Comtan (entacapone) shall impact the market growth. Loss of the patent would lead to the genericized market with entry of the generics of approved drugs in the market.

Levodopa combination drugs HOLDS maximum market share as compared to the other therapeutic class of drugs such as Dopamine Agonists, Monoamine Oxidase Inhibitors (MAOIs), Catechol-O-methyl transferase (COMT) Inhibitors, Peripheral Decarboxylase Inhibitors and others.

During the forecasted period, drugs administered via oral route would dominate the market as compared to drugs administered via subcutaneous, transdermal and other route of administration owning to the availability of maximum number of drugs in the tablet and capsule form.



About Author


Rahul Sankrityayan

Rahul Sankrityayan

Fortified with a post-graduate degree in Computer Applications, Rahul Sankrityan writes for AlgosOnline, where he pens down news and articles spanning across segments of technology industry that excite him on a day-to-day basis. Rahul comes with a rich experience in t...

Read More

More from Rahul


Post Recommendents

Rare Earth Metals Market to cross $20 bn by 2024
Author: Rahul Varpe

According to a new research report by Global Market Insights, Inc. Rare Earth Metals Market size will exceed USD 20 billion by 2024.

Cerium, and lanthanum are found out to be the major metals in terms of volume over the forecast period. ...


Global Automotive Lighting Market Detail Analysis focusing on Key Players like General Electric Company, HELLA GmbH & Co. KGaA, Hyundai MOBIS, Koito Manufacturing Co., Ltd, Magneti Marelli S.p.A & more
Author: Partha Ray

MarketStudyReport.com offers 2018 report on global Automotive Lighting market that evaluates industry growth trends through historical data and estimates future prospects based on comprehensive research. The report extensively provides the market ...


Hybrid Solar Wind Energy Storage Market 2024 Key Information by Top Key Players Siemens Gamesa, UNITRON, Grupo Dragon, ReGen Powertech, General Electric, Goldwind, Suzlon
Author: Partha Ray

Market Study Report adds global Hybrid Solar Wind Energy Storage market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming...